Immunological Dynamics in Colorectal Cancer

The interplay between tumour cells and the host immune system is a central driver of colorectal cancer development, progression and response to therapy. Tumour cells exploit mechanisms of immune evasion, including local recruitment of immunosuppressive cells and secretion of inhibitory cytokines, to subvert cytotoxic T-cell activity. In contrast, robust infiltration by effector lymphocytes, particularly CD8+ cytotoxic T cells, is associated with improved patient survival and underpins the concept of cancer immunosurveillance. Regulatory T cells, tumour‐associated macrophages and myeloid‐derived suppressor cells can dampen anti-tumour responses, while defects in DNA mismatch repair confer high microsatellite instability and generate neoantigens that enhance immunogenicity. Quantitative assessment of immune cell densities within distinct tumour regions has led to the development of the Immunoscore, which augments traditional staging by capturing the spatial organisation of T-cell subsets. Advances in spatial transcriptomics, multiplex imaging and computational pathology are now illuminating the dynamic evolution of the immune microenvironment during disease progression and treatment. Together, these insights are informing precision immunotherapy strategies, from checkpoint blockade in microsatellite‐instable cancers to novel combinations targeting suppressive myeloid pathways and stromal barriers.

Research from Nature Portfolio

A comprehensive meta-analysis of over forty cohort studies has established that high densities of intratumoural CD3+, CD8+ and FOXP3+ lymphocytes each confer a significant survival advantage in colorectal cancer. By pooling data across multiple intratumoural subsites—tumour centre, invasive margin and stroma—the analysis validated the prognostic value of tumour‐infiltrating lymphocytes (TILs) across diverse patient populations and treatment settings. These findings underpin the Immunoscore framework and reinforce the utility of standardised immune quantification as an independent biomarker beyond anatomical staging. The study’s breadth and methodological rigour have provided a foundational reference for subsequent clinical trials incorporating immune parameters into risk stratification.

Immunological Dynamics in Colorectal Cancer publication trend

The graph below shows the total number of articles in immunological dynamics in colorectal cancer across all publications each year (not limited to Nature Index journals).

Technical terms

Tumour microenvironment: The cellular milieu surrounding a tumour, comprising immune cells, stromal elements and vascular networks that influence tumour behaviour.

Tumour-infiltrating lymphocytes (TILs): Lymphocytes present within tumour tissue, reflecting the local immune response to cancer cells.

Immunoscore: A semi-quantitative index based on the densities of specific TIL subsets at defined tumour regions to predict clinical outcomes.

Microsatellite instability (MSI): A genetic hypermutation phenotype resulting from defective DNA mismatch repair, leading to increased neoantigen burden.

Epithelial-to-mesenchymal transition (EMT): A process by which epithelial cells acquire mesenchymal characteristics, including enhanced motility and invasiveness.

Regulatory T cells (Tregs): A subset of CD4+ T lymphocytes expressing FOXP3 that suppress effector immune responses and maintain tolerance.

References

1. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II–III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis. The Lancet Oncology (2024).
2. Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies. Journal of Clinical Oncology (2024).
3. IL-17RA signaling provides dual tumor-suppressor function during late-stage colorectal carcinogenesis. Immunity (2025).
4. Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes for prediction of prognosis in resected colon cancer. npj Precision Oncology (2023).
5. Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer. Archivum Immunologiae et Therapiae Experimentalis (2017).
6. The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis. Scientific Reports (2020).
7. Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy. Frontiers in Immunology (2022).